PartsTable
Technical Data Sheet
Download PDF

086207 — IOTHALAMATE MEGLUMINE INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

086207: IOTHALAMATE MEGLUMINE INJECTION.

IOTHALAMATE MEGLUMINE INJECTION. Key specifications include special_features: STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE)., primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 12, primary_container_content_quantity: 250.000 MILLILITERS, active_medicament_medicinal_strength: 17.200 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-255-0851, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
086207
NSN: 6505-01-255-0851
FSC: 6505 — Drugs and Biologicals
CAGE: 3FM41 — GUERBET LLC (USA)
SPECIFICATIONS
special_featuresSTORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE).
primary_container_typeBOTTLE
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity12
primary_container_content_quantity250.000 MILLILITERS
active_medicament_medicinal_strength17.200 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyIOTHALAMATE MEGLUMINE INJECTION USP 250ML PG OF 12S
american_hospital_formulary_service_classification_number366800
NSN6505-01-255-0851
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available IOTHALAMATE MEGLUMINE INJECTION TITLE COMPONENT PN 086207 MFR IOTHALAMATE MEGLUMINE
KEY FEATURES
•
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: BOTTLE
•
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 366800
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 17.200 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT
•
TOTAL PRIMARY CONTAINER QUANTITY: 12
TECHNICAL CHARACTERISTICS
PRIMARY CONTAINER CONTENT QUANTITY250.000 MILLILITERS
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEBOTTLE
SPECIAL FEATURESSTORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE).
PART NAME ASSIGNED BY CONTROLLING AGENCYIOTHALAMATE MEGLUMINE INJECTION USP 250ML PG OF 12S
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER366800
ACTIVE MEDICAMENT MEDICINAL STRENGTH17.200 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY12
SUBSTITUTES & CROSS-REFERENCES 2
CYSTO-CONRAY IIReference document
Same NSN cross-reference
Reference document — Secondary reference
03-1185Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy 086207?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is 086207?
086207 is a IOTHALAMATE MEGLUMINE INJECTION.
What parts can replace 086207?
There are 2 known substitutes for 086207: CYSTO-CONRAY II, 03-1185. Substitute compatibility should be verified for your specific system.
What is the NSN for 086207?
086207 is cataloged in the U.S. Government catalog under NSN 6505-01-255-0851. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — 086207